| Patent(s) and the Corresponding Patented Drug(s) |
Top |
| World Intellectual Property Organization (WIPO) |
| Patent ID |
WO201474805 |
| Title |
Selective Targeting of Cancer Stem Cells. |
| Applicant(s) |
Whitehead Institute for Biomedical Research |
| Representative Drug(s) |
D0ZG7E |
Drug Info
|
N.A. |
[1] |
| Patent ID |
WO2015136557 |
| Title |
Cancer Stem Cell Targeting Compounds. |
| Abstract |
The present invention provides compounds of formula (I), compositions, uses thereof and methods for inhibiting proliferation or obliterating cancer stem cells which includes killing; and/or inducing apoptosis in cancer stem cells. Included within the scope of such compounds, compositions, uses thereof and methods are those in which proliferation of cancer stem cells are selectively eradicated or inhibited. |
| Applicant(s) |
Godavari Biorefineries Limited |
| Patent ID |
WO2015136556 |
| Title |
Compounds for Eradicating or Inhibiting Proliferation of Cancer Stem Cells. |
| Abstract |
The present invention provides compounds of formula (I), compositions, uses thereof and methods for eradicating or inhibiting proliferation of cancer stem cells which includes killing; and/or inducing apoptosis in cancer stem cells. Included within the scope of such compounds, compositions, uses thereof and methods are those in which proliferation of cancer stem cells are selectively eradicated or inhibited. |
| Applicant(s) |
Godavari Biorefineries Limited |
| Patent ID |
WO201539187 |
| Title |
Stem Cell Modulation Ii. |
| Applicant(s) |
University of Canberra |
| Patent ID |
WO201497318 |
| Title |
Agents for Eliminating Tumor-Initiating Cells. |
| Patent ID |
WO2014160401 |
| Title |
3-(Aryl or Heteroaryl)Methylene Indolin-2-One Derivatives As Inhibitors of Cancer Stem Cell Pathway Kinases for The Treatment of Cancer. |
